Business Description
RUA Life Sciences PLC
ISIN : GB0033360586
Description
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 10.11 | |||||
Equity-to-Asset | 0.88 | |||||
Debt-to-Equity | 0.05 | |||||
Debt-to-EBITDA | -0.25 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 2.09 | |||||
Beneish M-Score | -2.37 | |||||
WACC vs ROIC |
Growth Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -8.9 | |||||
3-Year EBITDA Growth Rate | 13.7 | |||||
3-Year EPS without NRI Growth Rate | 19.4 | |||||
3-Year FCF Growth Rate | 29.1 | |||||
3-Year Book Growth Rate | -32.8 |
Momentum Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 46.45 | |||||
9-Day RSI | 57.46 | |||||
14-Day RSI | 60.1 | |||||
6-1 Month Momentum % | 13.95 | |||||
12-1 Month Momentum % | -15.52 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 9.01 | |||||
Quick Ratio | 8.81 | |||||
Cash Ratio | 7.1 | |||||
Days Inventory | 97.33 | |||||
Days Sales Outstanding | 31.87 | |||||
Days Payable | 107.59 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -40.9 | |||||
Shareholder Yield % | 0.54 |
Profitability Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 81.06 | |||||
Operating Margin % | -88.41 | |||||
Net Margin % | -65.72 | |||||
FCF Margin % | -63.12 | |||||
ROE % | -27.69 | |||||
ROA % | -23.24 | |||||
ROIC % | -33.86 | |||||
ROC (Joel Greenblatt) % | -67.95 | |||||
ROCE % | -33.99 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 2.13 | |||||
PB Ratio | 1.23 | |||||
Price-to-Tangible-Book | 1.43 | |||||
EV-to-EBIT | -2.74 | |||||
EV-to-Forward-EBIT | -4.75 | |||||
EV-to-EBITDA | -3.37 | |||||
EV-to-Forward-EBITDA | -6.53 | |||||
EV-to-Revenue | 2.42 | |||||
EV-to-Forward-Revenue | 1.58 | |||||
EV-to-FCF | -3.83 | |||||
Price-to-Median-PS-Value | 0.37 | |||||
Price-to-Net-Current-Asset-Value | 2.38 | |||||
Price-to-Net-Cash | 2.85 | |||||
Earnings Yield (Greenblatt) % | -36.5 | |||||
FCF Yield % | -15.64 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
RUA Life Sciences PLC Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil £) | 2.191 | ||
EPS (TTM) (£) | -0.053 | ||
Beta | -0.55 | ||
Volatility % | 114.97 | ||
14-Day RSI | 60.1 | ||
14-Day ATR (£) | 0.0087 | ||
20-Day SMA (£) | 0.139125 | ||
12-1 Month Momentum % | -15.52 | ||
52-Week Range (£) | 0.085 - 0.5875 | ||
Shares Outstanding (Mil) | 62.06 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
RUA Life Sciences PLC Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
RUA Life Sciences PLC Stock Events
Event | Date | Price(£) | ||
---|---|---|---|---|
No Event Data |
RUA Life Sciences PLC Frequently Asked Questions
What is RUA Life Sciences PLC(LSE:RUA)'s stock price today?
When is next earnings date of RUA Life Sciences PLC(LSE:RUA)?
Does RUA Life Sciences PLC(LSE:RUA) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |